Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Rheumatoid arthritis is associated with increased cardiovascular morbidity and mortality due to atherosclerosis. This cannot be explained by an increased presence of traditional risk factors but seems to depend on inflammatory mechanisms. The association of inflammatory pathways with atherosclerosis is complex, and more research is required to optimise preventative measures against cardiovascular complications in inflammatory rheumatic diseases.


Journal article


Ugeskr Laeger

Publication Date





3304 - 3308


Anti-Inflammatory Agents, Anticholesteremic Agents, Arthritis, Rheumatoid, Atherosclerosis, Cardiovascular Diseases, Cytokines, Humans, Immunosuppressive Agents, Inflammation Mediators, Risk Factors